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Abstract
Introduction The etiology of degenerative disc disease is
unknown. Several investigators have reported the presence of
proteolytic enzymes, such as the matrix metalloproteinase
(MMP) and ADAMTS (a disintegrin and metalloprotease with
thrombospondin-like repeats) families, in degenerated human
discs. Glasson and colleagues recently reported that a
significant reduction occurs in the severity of cartilage
destruction in ADAMTS5 knockout mice compared with wild-
type mice. The purpose of this study was to evaluate the
suppressive effects of injections of ADAMTS5  small
interference RNA (siRNA) oligonucleotide on intervertebral disc
degeneration in the rabbit anular needle-puncture model.
Methods Rabbit nucleus pulposus (NP) cells were transfected
with siRNA oligonucleotides specific for ADAMTS5  or the
control. The suppression of the ADAMTS5  gene by siRNA
transfection was assessed by using real-time polymerase chain
reaction (PCR), both in monolayer and alginate bead cultures
with or without interleukin-1β (IL-1β) stimulation. The effect of
siRNA was determined in vivo by using the rabbit anular needle-
puncture model (control group: n = 8; ADAMTS5 group: n = 8).
One week after the initial anular puncture, the animals received
an injection of the control or anti-ADAMTS5  oligonucleotide
(100 μg each at the L2/3 and L4/5 level; 16 discs/group). Disc
height, magnetic resonance imaging (MRI) (Thompson
classification and signal intensity), and safranin-O staining
(histologic grade) were assessed.
Results IL-1β treatment significantly increased the ADAMTS5
mRNA level in NP cells (P  < 0.01). ADAMTS5  gene
suppression was 70% compared with the control
oligonucleotide in both monolayer and alginate bead culture
with or without stimulation with IL-1β. The injection of anti-
ADAMTS5 oligonucleotide in vivo resulted in improved MRI
scores with increased signal intensity and improved histologic
grade scores with statistical significance (P  < 0.05). No
significant change in disc height was observed.
Conclusions A single injection of ADAMTS5 siRNA induced
the suppression of degradation in NP tissues, as shown by
significantly improved MRI and histologic grades. The
mechanism of response to siRNA may be worthy of exploration
for possible therapeutic purposes.
ADAMTS: a disintegrin and metalloprotease with thrombospondin-like repeats; AF: anulus fibrosus; CT: comparative threshold; DHI: disc height index; 
GAPDH: glyceraldehyde 3-phosphate dehydrogenase; IL-1β: interleukin-1β; IVD: intervertebral disc; MMP: matrix metalloproteinase; MRI: magnetic 
resonance imaging; NP: nucleus pulposus; PBS: phosphate-buffered saline; PCR: polymerase chain reaction; RT-PCR: reverse transcriptase-
polymerase chain reaction; siRNA: small interference RNA; TNF-α: tumor necrosis factor-α.Arthritis Research & Therapy    Vol 11 No 6    Seki et al.
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Introduction
The intervertebral disc (IVD) encompasses two structures, the
anulus fibrosus (AF) and the nucleus pulposus (NP). The pre-
dominant matrix component of the AF is collagen type I,
whereas the NP contains randomly organized collagen fibers
(mainly type II) and highly hydrated proteoglycans, primarily
aggrecan, which impart compressive resistance to the tissue.
Aggrecan is cleaved at a specific "aggrecanase" site [1,2];
this cleavage results from the action of several members of the
ADAMTS (adisintegrin and metalloprotease with throm-
bospondin-like repeats) family [3-6]. In a murine model of oste-
oarthritis,  ADAMTS5-knockout mice have a significantly
reduced level of cartilage destruction, compared with wild-
type mice [7]. Glasson and colleagues [8] also reported that
no effect in ADAMTS4 knockout mice was noted on the pro-
gression or severity of osteoarthritis after surgical induction of
joint instability. However, the dual deletion of ADAMTS4 and
ADAMTS5 provided significant protection against proteogly-
can degradation ex vivo and decreased the severity of murine
osteoarthritis in vivo [9].
Compared with cartilage, the NP has a higher content of
aggrecan that is more degraded and a higher proportion of
molecules not bound to hyaluronan [10]. A recent human
cadaveric study revealed the presence of aggrecanase-gener-
ated aggrecan fragments and abundant levels of ADAMTS5 in
human IVDs, regardless of the level of disc degeneration,
based on magnetic resonance imaging (MRI) grade classifica-
tion [11]. This study also showed that larger quantities of
ADAMTS4 are present in human NP and AF tissues derived
from discs with a greater level of disc degeneration (grade 4)
compared with those from discs with lower level of disc
degeneration (grade 2). Thus, it remains unclear whether
ADAMTS4 or ADAMTS5 is the major aggrecanase responsi-
ble for degradation of aggrecan in the human IVD. Modulating
the enzymatic activity or gene expression of the responsible
enzymes might be a valid approach for protecting human IVD
tissues from degradation.
IVDs of patients with lumbar disc herniation have been shown
to express proinflammatory cytokines, such as interleukin-1β
(IL-1β) and tumor necrosis factor-α (TNF-α) [12,13], which are
known to stimulate the expression of ADAMTS in bovine carti-
lage [14,15]. The regulation of ADAMTS4 and ADAMTS5 has
been reported to differ slightly. For example, although a highly
selective inhibitor of IκB kinase did not inhibit the secretion of
ADAMTS4, it blocked ADAMTS5 secretion in the same con-
centration range that inhibited aggrecan degradation in bovine
cartilage [15]. Furthermore, whereas ADAMTS5 mRNA was
expressed in human normal and OA cartilage [16], ADAMTS4
mRNA was very low in vivo and was induced in vitro only after
stimulation with IL-1β. These results suggest that investigating
both ADAMTS4 and ADAMTS5 may shed light on the mech-
anism of IVD degeneration.
Biologic treatment strategies for human IVD degeneration
include increasing the levels of anabolic growth factors or
blocking the catabolic cascade or both. On the anabolic side,
an in vivo rabbit anular puncture model of disc degeneration
showed the anabolic effects of bone morphogenetic protein-7
[17] and growth and differentiation factor-5 [18]. The anticat-
abolic effects of factors, such as caspase inhibitor [19], tissue
inhibitor of metalloproteinase-1 [20], IL-1 receptor, anti-TNF-α
antagonists [12,21,22], and others have been shown on the
extracellular matrix metabolism of IVD cells in vitro.
The anticatabolic role of the specific inhibition of ADAMTS4
and  ADAMTS5  in human cartilage was recently found by
using a small interfering RNA (siRNA) approach in normal and
osteoarthritic explants [23]. To date, no report has been made
that an anticatabolic factor suppresses IVD degeneration in
vivo. The purpose of this study was to prove our hypothesis
that a single injection of ADAMTS5 siRNA inhibits the produc-
tion of ADAMTS5 and suppressed IVD degeneration in the
rabbit anular needle-puncture model.
Materials and methods
In vitro study
Cell preparation and alginate bead culture
Lumbar IVDs from four consecutive levels (L2/3, L3/4, L4/5,
and L5/S1) were dissected from the spines of adolescent Jap-
anese white rabbits (1 to 1.5 kg, 6 to 9 weeks old) after killing
by injection of an excess amount of sodium pentobarbital
(Dainippon Pharmaceutical, Osaka, Japan). Tissues were sep-
arately harvested from the NP and the outer layer of the AF,
and the cells were isolated by using a sequential proteinase
and collagenase digestion, as previously described [24]. Pri-
mary cells were expanded in monolayer culture in complete
media (Dulbecco's Modified Eagles Medium (DMEM) supple-
mented with 10% FBS, 100 U/ml penicillin, 100 μg/ml strep-
tomycin, and 0.5 μg/ml amphotericin B (Fungizone)). After one
passage, cells were suspended in sodium alginate (1.2% solu-
tion in 155 mM NaCl; Cambrex CC-3234, Charles, Iowa,
USA) at a density of 5 × 105 cells/ml. The beads were main-
tained for up to 14 days with Chondrocyte Differentiation
Media (Cambrex CC-3225) and seeded in a 12-well plate at a
density of 1 × 105 cells/well.
Establishment of siRNA for ADAMTS5 oligonucleotide 
and transient transfection
The siRNA oligonucleotide for the rabbit ADAMTS5 gene was
constructed from a completely homologous region of
sequences in the ADAMTS5  gene of the human, rat, and
mouse from the NCBI website [25]. The reverse transcriptase-
polymerase chain reaction (RT-PCR) primers were con-
structed from this homologous region, and RT-PCR was com-
pleted. PCR products were collected, and the rabbit
ADAMTS5 gene was cloned by using the TA Cloning Kit (Inv-
itrogen, Carlsbad, CA, USA) and confirmed by sequencing by
using the ABI PRISM 310. Sequences for primers used inAvailable online http://arthritis-research.com/content/11/6/R166
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these analyses were as follows: 5'-CTCCCAGGACAAAC-
CTACGA-3' and 5'-CCTCTTCCCTGTG CAGTAGC-3' for
ADAMTS5 cDNA amplification. SiRNA for the ADAMTS5 oli-
gonucleotide was constructed by using the Takara Website
[26]. Sequences for the control and ADAMTS5 oligonucle-
otides of the siRNA used in these analyses were as follows:
sense oligonucleotide 5'-CGAUCCUCAAAGCACUACUTT-
3', anti-sense oligonucleotide 5'-AGUA GUGCUUUGAG-
GAUCGTT-3' for the control, sense oligonucleotide 5'-CCAC-
CAUCACG GAAUUCCUTT-3', and anti-sense
oligonucleotide 5'-AGGAAUUCCGUGAUGGUGGTT-3' for
ADAMTS5. Sense and antisense oligonucleotide siRNAs
were separately dimerized for the control and ADAMTS5.
Confirmation of the knockdown rate of the ADAMTS5 
GENE with or without IL-1β stimulation in monolayer 
culture
A standard for the rabbit ADAMTS5 gene was constructed
from the sequence originally analyzed. For transient transfec-
tion, NP cells were seeded in a 12-well plate at a density of 1
× 105 cells/well and cultured in complete media.
Effect on constitutive expression
After 48 hours, the NP cells were transiently transfected with
the anti-ADAMTS5 oligonucleotide or control oligonucleotide,
added directly to media without transfection reagents. After
48 hours' incubation, the cells were harvested, and the mRNA
level of ADAMTS5 was assessed.
Effect on IL-1β-stimulated expression
After 48-hour preculture, cells were cultured with or without IL-
1β (10 ng/ml) (Roche, Mannheim, Germany) in serum-free
DMEM. After 24 hours of IL-1 treatment, anti-ADAMTS5 oligo-
nucleotide or control oligonucleotide was added to the culture
for transfection. After 24 hours' incubation with siRNA, NP
cells were collected and subjected to mRNA analysis.
Confirmation of the knockdown rate of the ADAMTS5 
gene by "siSTABLE" siRNA in alginate bead culture
Freshly prepared stable anti-ADAMTS5  oligonucleotide
(Dharmacon siSTABLE, Thermo Scientific, Lafayette, CA,
USA) was prepared for in vivo experiments, but first tested in
an in vitro alginate culture system. NP cells were cultured in
alginate beads, as described earlier. After 14 days, NP cells in
alginate beads were transfected with anti-ADAMTS5 oligonu-
cleotide or control oligonucleotide (Dharmacon) without trans-
fection reagents. Results are reported normalized to GAPDH.
RNA isolation and real-time PCR
Total RNA was extracted from transfected cells by using Iso-
gen (Nippongene, Tokyo, Japan) and purified with the SV Total
RNA Isolation System (Promega, Madison, WI, USA).
Random-primed cDNAs were synthesized by using Multi-
scribe reverse transcriptase (PE Applied Biosystems, Foster,
CA, USA). Quantitative real-time PCR was carried out by
using a PRISM 7700 sequence detector with the QuantiTect
SYBR Green PCR kit (Qiagen, Valencia, CA, USA) according
to the manufacturer's instructions. The relative expression of
ADAMTS5 was calculated by using the comparative threshold
(CT) method, as previously described [27]. Results are
reported normalized to the housekeeping gene glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH).
In vivo study
Establishment of a degenerative IVD by using the rabbit 
anular needle-puncture model and injection of the anti-
ADAMTS5 oligonucleotide
An anular puncture model was established by using an 18-
gauge needle at a defined depth of puncture (5 mm), as previ-
ously reported [28]. New Zealand white rabbits (n = 12),
weighing approximately 3.5 to 4.0 kg (5 months old), were
used in this study with the approval of the Institutional Animal
Care and Use Committee (06-067). Under general anesthe-
sia, lumbar IVDs were exposed, and the initial puncture with an
18-gauge needle was performed on two noncontiguous discs
(L2/3 and L4/5), with the disc (L3/4) between the punctured
discs left intact as a control [17]. One week after the initial
puncture, the discs were exposed again from the contralateral
side, and either control siRNA or ADAMTS5 siRNA oligonu-
cleotide (Dharmacon, was injected into the center of the NP by
using a 26-gauge needle (10 μg in 10 μl phosphate-buffered
saline (PBS) per disc). The timing of injection was earlier than
that used in other studies [17,18] to reveal the effect of an
injection of ADAMTS5 siRNA during the acute phase of disc
degeneration. Nine weeks after the initial anular puncture (8
weeks after the injection), all rabbits were killed.
Radiographic analysis of disc height
Radiographs were taken at time 0 and at weeks 1, 2, 3, 5, 7,
and 9 after the puncture. Extreme care was taken to maintain
a consistent level of anesthesia during radiography of each
animal at each time point to obtain a similar degree of muscle
relaxation, which may affect the disc height. Therefore, the pre-
operative radiograph was always used as a baseline measure-
ment. Radiographs were digitally scanned and digitally stored
by using an image-capture software program.
Image analysis
All radiographic images were independently analyzed by using
a custom program for MATLAB software (Natick, MA, USA) by
an orthopedic researcher who was blinded to the treatment
groups. Data are reported as the IVD height expressed as the
disc-height index (DHI) (DHI = intervertebral disc height/adja-
cent vertebral body height) [17]. Changes in the disc-height
index of injected discs were expressed as percentage DHI
(%DHI) and normalized to the measured preoperative interver-
tebral disc height (%DHI = (Postoperative DHI/Preoperative
DHI) × 100) [17]. To avoid the influence of anesthesia, the
%DHI at the experimental level was further normalized toArthritis Research & Therapy    Vol 11 No 6    Seki et al.
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%DHI at the nonpunctured level (normalized %DHI = (Punc-
tured %DHI/Nonpunctured %DHI) × 100).
MRI assessment
MRI examinations were performed on all rabbits in the study by
using a 0.3-T imager (Airis II, version 4.0 A; Hitachi Medical
System America, Inc., Twinsburg, Ohio, USA) with a quadra-
ture extremity coil receiver. After killing, the spinal columns
with surrounding soft tissue were isolated and subjected to
MRI analysis [17]. An observer, blinded to the study groups,
used a modified Thompson classification based on changes in
the degree and area of signal intensity from grade 1 to 4 (1 =
normal, 2 = minimal decrease in signal intensity but obvious
narrowing of high-signal area, 3 = moderate decrease in signal
intensity, and 4 = severe decrease in signal intensity) to eval-
uate the MRIs. The intraobserver and interobserver reliability
correlation coefficients of MRI grading based on two evalua-
tions were excellent (K = 0.98, 0.90, respectively), as deter-
mined by the Cohen kappa correlation coefficient [28].
Histologic evaluations
After MRI assessment, the experimental IVDs were excised
from the vertebral body-disc-vertebral body unit, and each IVD
was fixed in 10% formalin, decalcified, embedded in paraffin,
sectioned, and assessed with conventional histology and
immunostaining. Midsagittal sections (5 μm) of each IVD were
stained either with hematoxylin and eosin or with safranin-O.
An observer, blinded to the experiment, analyzed the histologic
sections and graded them by using our recently established
protocol [28].
Statistics
The %DHI was statistically analyzed by using a two-way
repeated analysis of variance and Fisher protected least signif-
icant difference as a post hoc test (factors; time and treatment
group). Other statistical analyses were assessed with the




Rabbit NP cells were chosen because their response to IL-1β
was more consistent than that of AF cells (as determined from
previous experiments) and because the injection site in the NP
has a higher concentration of proteoglycans. The effective-
ness of administration of ADAMTS5 siRNA might be influ-
enced by the rich positively charged matrix in NP tissues.
Effect of siRNA on rabbit ADAMTS5 gene expression in 
rabbit NP cells cultured in monolayer with or without 
stimulation with IL-1B
We confirmed that the siRNA oligonucleotide we constructed
knocked down the ADAMTS5 gene in rabbit NP cells. At 48
hours after transfection, the NP cells that received the
ADAMTS5  siRNA oligonucleotide showed approximately a
75% knockdown of constitutive expression of ADAMTS5
mRNA (Figure 1). This suppression was observed in all three
experiments. Real-time PCR revealed that IL-1β treatment for
24 hours increased the abundance of mRNA for ADAMTS5
(about 12-fold) in a dose-dependent manner in rabbit NP cells
(Figure 2a). Based on these results, a concentration of IL-1β
of 10 ng/ml was chosen for further studies. Subsequently,
after IL-1β treatment at 10 ng/ml for 24 hours, NP cells were
transfected with ADAMTS5 and control siRNA. At 24 hours
after the transfection, the abundance of ADAMTS5  mRNA
was knocked down by 70% compared with the control group
in rabbit NP cells (Figure 2b). This effect persisted for 2 weeks
(data not shown).
Effect of adamts5 oligonucleotide on rabbit NP cells 
cultured in alginate beads
It is possible that the injected siRNA cannot penetrate the
matrix of the target tissue and induce metabolic changes. To
confirm our hypothesis that ADAMTS5 siRNA has an effect in
a three-dimensional environment, the efficacy of ADAMTS5
was tested by using the alginate bead-culture system. We
confirmed that the ADAMTS5 gene was significantly knocked
down by using ADAMTS5 siRNA with no transfection reagent.
The knockdown rate of the ADAMTS5 siRNA cells was 70%
Figure 1
Establishment of small interfering RNA (siRNA) oligonucleotide for  ADAMTS5 in rabbit nucleus pulposus (NP) cells Establishment of small interfering RNA (siRNA) oligonucleotide for 
ADAMTS5 in rabbit nucleus pulposus (NP) cells. After the 48-hour pre-
culture period, rabbit NP cells were transfected with the siRNA oligonu-
cleotide specific for either the control or ADAMTS5. At 48 hours after 
transfection in NP cells, the ADAMTS5 siRNA-transfected cells 
showed approximately a 75% knock-down of ADAMTS5 mRNA com-
pared with the control siRNA. The results are reported normalized to 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH).Available online http://arthritis-research.com/content/11/6/R166
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Radiographic assessments were performed to confirm that the
rabbits received identical punctures with an 18-gauge needle
at the correct levels. The needle puncture was found to have
reduced the %DHI at 1 week (70% DHI; P > 0.06, Figure 4),
with no significant difference in %DHI between the two
groups. At that time, the control oligonucleotide or anti-
ADAMTS5 oligonucleotide (100 μg in 10 μl of PBS) was
administered into the NP of the rabbit IVDs. After the siRNA
injections, no significant differences were found in the %DHI
between the control siRNA and the ADAMTS5 siRNA groups
during the observation period (Figure 4).
MRI analysis
MRI analysis was performed at 8 weeks after the siRNA injec-
tions when the animals were killed. The MRI of the NP in the
ADAMTS5 siRNA group showed a stronger T2 signal intensity
than that found in the Control group (Figure 5). When disc
degeneration was assessed by using the Thompson MRI grad-
ing score, the grading score was significantly lower (better) in
the ADAMTS5 siRNA group than in the control siRNA group
(P = 0.02, Mann-Whitney U test) (Figure 6).
Figure 2
Effect of interleukin-1β (IL-1β) stimulation on ADAMTS5 mRNA expression in rabbit nucleus pulposus (NP) cells Effect of interleukin-1β (IL-1β) stimulation on ADAMTS5 mRNA expression in rabbit nucleus pulposus (NP) cells. After real-time polymerase chain 
reaction (PCR), the ADAMTS5 mRNA expression level after IL-1β stimulation (24 hours) in rabbit NP cells is shown (a). IL-1β at 10 ng/ml induced 
the highest level of increased expression of mRNA for ADAMTS5 (about 12-fold); that concentration was chosen for subsequent studies. (b) NP 
cells seeded in a 12-well plate at a density of 1 × 105 cells/well. After the 48-hour preculture period, cells were cultured in serum-free media in the 
presence of IL-1β (10 ng/ml) for 24 hours. After the 24-hour treatment with IL-1β, NP cells were transiently transfected with the anti-ADAMTS5 oli-
gonucleotide or control oligonucleotide by adding oligonucleotide directly to the culture media. Twenty-four hours later, NP cells were collected, and 
the expression of ADAMTS5 was analyzed with real-time PCR. ADAMTS5 mRNA expression was knocked down by about 70% in rabbit NP cells 
that were transfected with ADAMTS5 siRNA and stimulated with IL-1β (10 ng/ml). The results are reported normalized to GAPDH.
Figure 3
Effect of ADAMTS5 oligonucleotide on rabbit nucleus pulposus (NP)  cells in alginate bead culture Effect of ADAMTS5 oligonucleotide on rabbit nucleus pulposus (NP) 
cells in alginate bead culture. NP cells were suspended in sodium algi-
nate at a density of 5 × 105 cells/ml and maintained for up to 14 days. 
After 14 days, the NP cells in alginate beads were transfected with anti-
ADAMTS5 oligonucleotide or control oligonucleotide without using 
gene-delivery reagents. In NP cells in alginate bead culture, the expres-
sion of the ADAMTS5 gene was approximately 70% of that seen with 
the control oligonucleotide. The results are reported normalized to 
GAPDH.Arthritis Research & Therapy    Vol 11 No 6    Seki et al.
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Histologic evaluation
The injection of ADAMTS5 siRNA significantly affected the
histochemical changes found with IVD degeneration. Eight
weeks after the control or ADAMTS5 siRNA injections, the
control siRNA group displayed a complete loss of NP tissues,
which had been replaced by a fibrocartilaginous tissue (Figure
7a and 7c). The severely degenerated discs that had received
the control siRNA showed a loss of proteoglycans and the col-
lapsed, wavy fibrocartilage lamellae typical of the AF with
associated fibrochondrocytes (Figure 7e and 7g). In the discs
that received the ADAMTS5 siRNA, safranin-O staining dem-
onstrated the maintenance of IVD structure with a lightly
stained matrix and large cells (Figure 7b and 7d); the NP was
rounded and well filled with numerous large, vacuolated cells
and smaller chondrocyte-like cells typical of the normal IVD
(Figure 7f and 7h). The histologic grading scores demonstrate
that the cellularity and matrix of the NP in the ADAMTS5
siRNA-treated discs were significantly lower (better) than
those in the control siRNA group (Figure 8). The total grading
score (SUM) in the ADAMTS5 siRNA-treated discs was also
significantly lower than those in the control siRNA group
(Mann-Whitney; P < 0.05) (Figure 8). The scores for the AF
and the border between the AF and NP in the ADAMTS5
siRNA-treated discs showed a trend to be lower than those in
the control discs (Mann-Whitney; AF; P  = 0.06; border
between the AF and NP; P = 0.08).
Discussion
With the rabbit anular puncture model, this study explored the
efficacy of a direct injection of ADAMTS5 siRNA into the NP
on the delay or attenuation of disc degeneration. Our results
demonstrate that the designed ADAMTS5  siRNA was (a)
active in vitro and (b) effective in suppressing the degenera-
tion of the NP tissue in the in vivo rabbit model. However, the
injection of ADAMTS5 siRNA did not induce the anticipated
recovery of disc height.
We successfully designed and constructed an siRNA oligonu-
cleotide with biologic activity for the rabbit ADAMTS5 gene.
ADAMTS5 siRNA-transfected rabbit NP cells showed approx-
imately a 75% knockdown of ADAMTS5 mRNA compared
with the control siRNA. Although we demonstrated that IL-1β
treatment significantly increased the ADAMTS5 mRNA level in
NP cells, the suppression of the expression of the ADAMTS5
gene by ADAMTS5 siRNA was 70% compared with the con-
trol oligonucleotide in both monolayer and alginate bead cul-
ture under stimulation with IL-1β.
Figure 4
Radiographic assessment in the rabbit anular puncture model of disc  degeneration Radiographic assessment in the rabbit anular puncture model of disc 
degeneration. An anular puncture model was established in 5-month-
old New Zealand white rabbits. Under general anesthesia, lumbar 
intervertebral discs were exposed, and the initial puncture with an 18-
gauge needle at a defined depth of puncture (5 mm) was performed on 
two noncontiguous discs (L2/3 and L4/5), with the disc (L3/4) 
between the punctured discs left intact as a control. One week after 
the initial puncture, either control small interfering RNA (siRNA) or 
ADAMTS5 siRNA oligonucleotide (10 μg in 10-μl phosphate-buffered 
saline (PBS) per disc) was injected into the center of the nucleus pul-
posus by using a 26-gauge needle. Nine weeks after the initial anular 
puncture (8 weeks after the injection), all rabbits were killed. Radio-
graphs were taken at time 0 and at weeks 1, 2, 3, 5, 7, and 9 after the 
puncture to quantity changes in the disc-height index (DHI). The %DHI 
was calculated as [%DHI = (Postoperative DHI/Preoperative DHI) × 
100]. At 8 weeks after the ADAMTS5 siRNA injection, no difference 
was found in the mean %DHI of the ADAMTS5 siRNA-injected punc-
tured discs compared with the punctured discs that received the con-
trol siRNA injection (P > 0.05, repeated ANOVA).
Figure 5
Magnetic resonance imaging (MRI) findings after small interfering RNA  (siRNA) oligonucleotide injection in the rabbit anular puncture model of  disc degeneration Magnetic resonance imaging (MRI) findings after small interfering RNA 
(siRNA) oligonucleotide injection in the rabbit anular puncture model of 
disc degeneration. MRI examinations were performed on all spinal col-
umns isolated from the rabbits ex vivo at death 8 weeks after the siRNA 
oligonucleotide injection. In these representative MRIs, the T2 signal 
intensity in the nucleus pulposus of the ADAMTS5 siRNA-injected 
discs was stronger than that in the control siRNA-injected discs.Available online http://arthritis-research.com/content/11/6/R166
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The intradiscal injection of ADAMTS5 siRNA during the acute
phase of disc degeneration after anular puncture in the rabbit
delayed the progression of disc degeneration, as assessed by
MRI scores, signal intensity of NP on MRI, and histologic
scores. MRI findings of a high T2 signal intensity in the NP indi-
cate that the NP in the punctured discs treated with
ADAMTS5 siRNA was hydrated. Therefore, ADAMTS5, which
cleaves the core protein of aggrecan, may significantly contrib-
ute to the loss of water content of the NP after anular puncture.
However, the reason that the disc height loss was not
reversed by the injection of ADAMTS siRNA remains to be
determined. One possible explanation is that the treatment
with siRNA for ADAMTS5 is an anticatabolic one, not ana-
bolic. In addition, a possibility remains that the injected siRNA
was retained in the NP area, where the siRNA was injected, by
some mechanism, or mainly internalized by NP cells and did
not distribute to the AF area. In a previous study using the rab-
bit anular puncture model, the injection of osteogenic protein-
1 into the NP induced an increased proteoglycan content of
both the AF and the NP and the recovery of disc-height loss
by 6 weeks [17]. One could speculate that the maintenance of
disc height is determined by the structural integrity of the anu-
lus, which could not be fully assessed through MRI and histol-
ogy in a quantitative fashion. Furthermore, we did not test
different doses of ADAMTS5 siRNA in the anular puncture
model, nor did we assess the half-life of injected siRNA. The
limited effects of ADAMTS5 siRNA may point to a complex
involvement of multiple enzymes in disc degeneration. Never-
theless, the strong suppression of the ADAMTS5 gene by
siRNA in vitro and in vivo, especially in NP tissues, indicates
that ADAMTS5 might play an important role in IVD degenera-
tion.
Histologic findings from safranin-O staining were supportive of
the maintenance of NP tissues in the ADAMTS5  siRNA-
Figure 6
Magnetic resonance imaging (MRI) assessment 8 weeks after small  interfering RNA (siRNA) injection in the rabbit anular puncture model of  disc degeneration Magnetic resonance imaging (MRI) assessment 8 weeks after small 
interfering RNA (siRNA) injection in the rabbit anular puncture model of 
disc degeneration. An observer blinded to the study assessed the MRIs 
by using the modified Thompson scale, based on changes in the 
degree and area of signal intensity from grades 1 to 4. After assess-
ment of the MRI grades, a significantly lower (better) MRI grade in the 
ADAMTS5 siRNA-injected discs was observed compared with the 
control siRNA-injected discs (P = 0.02, Mann-Whitney test).
Figure 7
Safranin-O-stained sections reflecting typical histologic changes after  injection of control small interfering RNA (siRNA) or ADAMTS5 siRNA  in the rabbit anular puncture model of disc degeneration Safranin-O-stained sections reflecting typical histologic changes after 
injection of control small interfering RNA (siRNA) or ADAMTS5 siRNA 
in the rabbit anular puncture model of disc degeneration. Eight weeks 
after the control or ADAMTS5 siRNA injections, the control siRNA 
group displayed a complete loss of nucleus pulposus (NP) tissues, 
which had been replaced by a fibrocartilaginous tissue (a, c). The 
severely degenerated discs that had received the control siRNA 
showed a loss of proteoglycans and the collapsed, wavy fibrocartilage 
lamellae typical of the anulus fibrosus (AF), with associated fibro-
chondrocytes (e, g). In the ADAMTS5 siRNA-injected discs, safranin-O 
staining demonstrated the maintenance of intervertebral disc structure 
with a lightly stained matrix and large cells (b, d); the NP was rounded 
and bloated looking, and consisted of numerous large, vacuolated cells 
and smaller chondrocyte-like cells (f, h). A clear demarcation was seen 
between the NP and inner anulus in the ADAMTS5 siRNA-injected 
discs. (Magnification ×20 (a-d), ×100 (e-h)). The level in a, b, e, and f is 
L2/3, and in c, d, g, and h is L4/5.Arthritis Research & Therapy    Vol 11 No 6    Seki et al.
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treated discs, as observed with MRI. The improving histologic
scores associated with the NP might indicate that ADAMTS5
is more involved in matrix degeneration of the NP than that in
the AF. In addition, the direct injection of siRNA into the NP
may induce a localized improvement. It is worth noting that the
histologic scores for the AF and the border between the AF
and NP in the ADAMTS5 siRNA-treated discs showed a trend
to be lower (improved) when compared with those for the con-
trol discs. These findings might indicate that the inhibition of
degeneration or improved reparative activity of the NP may
have contributed to the improved histologic grading for the AF
and the border between the AF and NP.
The treatment of human disc cells with IL-1 induced an imbal-
ance between catabolic and anabolic events, responses that
represent the changes seen during disc degeneration
[12,13,29]. After treatment with IL-1, the aggrecanases
(ADAMTS4, 5), matrix metalloproteinase-3 (MMP-3), and
MMP-13, gene expression was increased in cells derived from
the human NP cells [13]. Séguin and colleagues [30] reported
that induction of ADAMTS4 and -5 mRNA occurred down-
stream of NF-κβ activation in NP cells. These results, and the
recent reports on the contribution of IL-1 in disc degeneration
[31], may indicate that as disc degeneration progresses, more
ADAMTS5 is expressed in the IVD, with a high association
with an increased amount of IL-1.
In summary, we have shown evidence that the suppression of
ADAMTS5 in turn suppressed IVD degeneration; this sug-
gests the possible contribution of ADAMTS5 to disc degener-
Figure 8
Histologic assessment after ADAMTS5 small interfering RNA (siRNA) or control siRNA injection in the rabbit anular puncture model of disc degen- eration Histologic assessment after ADAMTS5 small interfering RNA (siRNA) or control siRNA injection in the rabbit anular puncture model of disc degen-
eration. In ADAMTS5 siRNA-injected discs, the anulus fibrosus (AF) and the border between the AF and nucleus pulposus (NP) showed a tendency 
to have a lower (better) histologic score than the control siRNA-injected discs (Mann-Whitney test; P < 0.1). In the NP, the cellularity, matrix, and 
total grading score (SUM) were significantly better in the ADAMTS5 siRNA-injected discs than in the control siRNA-injected discs (Mann-Whitney 
test; P < 0.05).Available online http://arthritis-research.com/content/11/6/R166
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ation, especially in the NP of the rabbit anular puncture model
of disc degeneration.
Conclusions
A single injection of ADAMTS5  siRNA suppressed disc
degeneration in the NP, as shown by the significantly improved
MRI and histologic grades. The results may suggest that
ADAMTS5 contributes to the degeneration of NP tissues in
the rabbit anular puncture disc-degeneration model. The
mechanism for the differences in response to siRNA in disc
height and MRI findings may be worthy of exploration.
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